Calyxt, Inc. (CLXT) financial statements (2021 and earlier)

Company profile

Business Address 2800 MOUNT RIDGE ROAD
ROSEVILLE, MN 55113
State of Incorp. DE
Fiscal Year End December 31
SIC 287 - Agricultural Chemicals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:30599457
Cash and cash equivalents17599457
Short-term investments12   
Other undisclosed cash, cash equivalents, and short-term investments1   
Restricted cash and investments000 
Receivables5100
Inventory, net of allowances, customer advances and progress billings13  
Inventory13  
Prepaid expense  1 
Other current assets  0 
Other undisclosed current assets3101
Total current assets:40649657
Noncurrent Assets
Property, plant and equipment23232214
Restricted cash and investments111 
Other noncurrent assets0000
Total noncurrent assets:24252315
TOTAL ASSETS:638811972
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6643
Accounts payable1111
Accrued liabilities3321
Employee-related liabilities2211
Debt00  
Due to related parties1121
Deferred revenue and credits0
Other liabilities001 
Other undisclosed current liabilities  0 
Total current liabilities:7774
Noncurrent Liabilities
Long-term debt and lease obligation1918  
Long-term debt, excluding current maturities2   
Finance lease, liability1818
Liabilities, other than long-term debt0000
Deferred revenue and credits0
Other liabilities000 
Other undisclosed noncurrent liabilities  1810
Total noncurrent liabilities:20181810
Total liabilities:26262515
Stockholders' equity
Stockholders' equity attributable to parent37639357
Common stock0000
Treasury stock, value(1)(1)(0) 
Additional paid in capital205186176112
Accumulated other comprehensive income 0  
Accumulated deficit(167)(122)(82)(55)
Total stockholders' equity:37639357
TOTAL LIABILITIES AND EQUITY:638811972

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues24701
Revenue, net1
Cost of revenue
(Cost of Goods and Services Sold)
(35)(9)  
Gross profit:(11)(2)01
Operating expenses(33)(38)(28)(26)
Operating loss:(44)(40)(28)(26)
Nonoperating income (expense)(0)21(0)
Investment income, nonoperating122 
Foreign currency transaction loss, before tax (0)(0)(0)
Interest and debt expense(1)(1)(1) 
Loss from continuing operations before equity method investments, income taxes:(45)(40)(28)(26)
Other undisclosed income (loss) from continuing operations before income taxes1  (0)
Net loss available to common stockholders, diluted:(45)(40)(28)(26)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(45)(40)(28)(26)
Other comprehensive income 0  
Comprehensive loss, net of tax, attributable to parent:(45)(40)(28)(26)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: